Scott Segal, M.B.A.

Mr. Segal has been a Director of EXUMA Biotech since January 2020.  Mr. Segal is a Managing Director at BDT & MSD Partners where he invests across a range of sectors, in both debt and structured equity.  He joined MSD Partners (prior to its merger with BDT) in 2006 from the Boston Consulting Group where he provided consulting services to Fortune 500 executives.  Prior to the Boston Consulting Group, Mr. Segal worked at HarbourVest Partners and Salomon Brothers.

Mr. Segal received his B.A. with honors from Queen’s University in Kingston, Canada, and his M.B.A. with honors from The Wharton School, University of Pennsylvania.  Mr. Segal sits on the board of the Hudson Guild in New York City where he serves on the Executive Committee as the Treasurer.